Showing results (141-150 of 187) with videos related to

Sort By:
Pageof 19
Expert Review of Vaccines|May 29, 2023
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccineEddie Underwood, Lisa M Dunkle, Shabir A Madhi, et al.
The Canadian Journal of Cardiology|September 16, 2023
Outcomes of Severe Mitral Stenosis With the Revised Severity Criteria: Mitral Valve Replacement vs Percutaneous Mitral ValvuloplastyDae-Young Kim, Iksung Cho, Kyu Kim, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 13, 2024
Optimizing Percutaneous Mitral Valvuloplasty for Rheumatic Mitral Stenosis　- Clinical Significance of Changes in Mitral Valve AreaKyu-Yong Ko, Iksung Cho, Dae-Young Kim, et al.
Vaccine|June 6, 2025
Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19)Germán Áñez, Alice McGarry, Wayne Woo, et al.
Circulation. Cardiovascular Imaging|July 16, 2025
Long-Term Follow-Up in Severe Mitral Stenosis With Low Transmitral Diastolic Pressure Gradient: From MASTER RegistryIksung Cho, Dae-Young Kim, Jinseob Kim, et al.
European Heart Journal. Cardiovascular Imaging|December 31, 2024
Selecting the optimal candidates for percutaneous mitral valvuloplasty using multi-modality imagingHee Jeong Lee, Na Young Kim, Dae-Young Kim, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 2, 2025
Prognostic Value of Left Atrial Strain for Systemic Embolism in Rheumatic Mitral Stenosis with Sinus Rhythm: Implications for Anticoagulation StrategyIksung Cho, Seonhwa Lee, In-Cheol Kim, et al.
The Lancet. Infectious Diseases|March 9, 2024
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trialChijioke Bennett, Wayne Woo, Mark Bloch, et al.
The Journal of Infectious Diseases|July 25, 2024
Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical TrialChijioke Bennett, E Joy Rivers, Wayne Woo, et al.
Korean Circulation Journal|March 23, 2026
Temporal Trend of Cardiovascular Disease Burden Among Cancer Patients Between 2005 and 2022: Nationwide Population-Based Cohort Study in South KoreaIksung Cho, Seonhwa Lee, Jaehyeong Cho, et al.
Pageof 19